Truveta Research on increased speech delays in children during the pandemic published in JAMA Pediatrics
05. Dezember 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new research published in JAMA Pediatrics exploring the incidence of first-time speech delays in children under the age of...
Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors
04. Dezember 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Truveta, the company with a mission of saving lives with data, welcomes its first member from the life science industry to its Board of Directors....
Largest real-world study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss
27. November 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new comparative effectiveness research exploring weight loss among patients taking semaglutide (Ozempic) and tirzepatide...
Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research
08. November 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced the availability of more than 56.6 million clinical observations from more than 2.7 million echocardiogram reports from...
More than 50 organizations choose Truveta for the most complete, timely, and clean EHR data to study safety and effectiveness, improve patient care, and train medical AI
23. Oktober 2023 09:00 ET
|
Truveta
Bellevue, WASH., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Truveta announced today that it is partnering with more than 50 organizations in life sciences, healthcare, government, academic medical centers,...
Truveta advances security and privacy with Type 2 SOC 2 examination
11. Oktober 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Truveta today announced it has completed a Type 2 System and Organization Controls (SOC) 2 examination, which underscores Truveta’s commitments to...
Truveta and Mathematica partner to advance public health and health equity with real-world data
21. September 2023 09:00 ET
|
Truveta
BELLEVUE, Wash. and PRINCETON, New Jersey, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Truveta, a leading EHR data and analytics company, and Mathematica, a policy research and data analytics consultancy,...
Medical Components Inc. and Truveta partner to advance care for patients living with cancer and chronic kidney disease
12. September 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Medical Components, Inc. is partnering with Truveta to advance the use of real-world data to improve clinical care for patients battling cancer...
Truveta Data now includes medication dispense data to help address nation’s 7th leading cause of death
09. August 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced the addition of new in-depth medication dispense data to help researchers study safety and effectiveness, medication...
Truveta community expands to more than 40 healthcare and life science organizations with a shared mission of saving lives with data
17. Mai 2023 09:07 ET
|
Truveta
BELLEVUE, Wash., May 17, 2023 (GLOBE NEWSWIRE) -- Today Truveta, a leader in electronic health record (EHR) data and analytics, announces the expansion of its community to include new life science...